VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus

Biochemical Society Transactions

Volumn 37, Issue 6, 2009, Pages 1167-1170

  Waltenberger, Johannes ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Arteriogenesis; Diabetes mellitus; Endothelial dysfunction; Signal transduction; Vascular endothelial growth factor (VEGF)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BEVACIZUMAB; PEGAPTANIB; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; DIABETES MELLITUS; DRUG RECEPTOR BINDING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 70450174366     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371167     Document Type: Article

References (22)

1. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611
2. Yilmaz, A., Kliche, S., Mayr-Beyrle, U., Fellbrich, G. and Waltenberger, J. (2003) The antiapoptotic role of VEGFR-2 is mediated via inhibition of p38 MAPK. Biochem. Biophys. Res. Commun. 306, 730-736
3. Busse, R. and Fleming, I. (1996) Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 33, 181-194
4. Feener, E.P. and King, G.L. (1997) Vascular dysfunction in diabetes mellitus. Lancet 350, 9-13
5. Zeiher, A.M., Drexler, H., Saurbier, B. and Just, H. (1993) Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J. Clin. Invest. 92, 652-662
6. Heitzer, T., Yla-Herttuala, S., Luoma, J., Kurz, S., Munzel, T., Just, H., Olschewski, M. and Drexler, H. (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 93, 1346-1353
7. Hornig, B., Arakawa, N., Kohler, C. and Drexler, H. (1998) Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97, 363-368
8. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. and Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678
9. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J. and Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17629-17634
10. Tchaikovski, V., Fellbrich, G. and Waltenberger, J. (2008) The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler. Thromb. Vasc. Biol. 28, 322-328
11. Waltenberger, J., Lange, J. and Kranz, A. (2000) Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102, 185-190
12. Waltenberger, J. (2007) Stress testing at the cellular and molecular level to unravel cellular dysfunction and growth factor signal transduction defects: what molecular cell biology can learn from cardiology. Thromb. Haemostasis 98, 975-979
13. Tchaikovski, V., Olieslagers, S., Böhmer, F.-D. and Waltenberger, J. (2009) Diabetes mellitus activates signal transduction pathways resulting in VEGF resistance of human monocytes. Circulation 120, 150-159
14. Simons, M. (2005) Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J. Am. Coll. Cardiol. 46, 835-837
15. Abaci, A., Oguzhan, A., Kahraman, S., Eryol, N.K., Ünal, S., Arinc, H. and Ergin, A. (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99, 2239-2242
16. Werner, G.S., Richartz, B.M., Heinke, S., Ferrari, M. and Figulla, H.R. (2003) Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur. Heart J. 24, 1134-1142
17. van Golde, J.M., Ruiter, M.S., Schaper, N.C., Vöö, S., Waltenberger, J., Backes, W.H., Post, M.J. and Huijberts, M.S. (2008) Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes 57, 2818-2823
18. Clayton, J.A., Chalothorn, D. and Faber, J.E. (2008) Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ. Res. 103, 1027-1036
19. Chalothorn, D., Zhang, H., Smith, J.E., Edwards, J.C. and Faber, J.E. (2009) Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ. Res. 105, 89-98
20. Sasso, F.C., Torella, D., Carbonara, O., Ellison, G.M., Torella, M., Scardone, M., Marra, C., Nasti, R., Marfella, R., Cozzolino, D. et al. (2005) Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J. Am. Coll. Cardiol. 46, 827-834
21. Greenberg, J.I., Shields, D.J., Barillas, S.G., Acevedo, L.M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R.S., Angle, N. and Cheresh, D.A. (2008) A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809-813
22. Stockmann, C., Doedens, A., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J.I., Cheresh, D.A. and Johnson, R.S. (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456, 814-818